Related Experiment Video
Updated: Jul 19, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling
Md Sadique Hussain1, Obaid Afzal2, Gaurav Gupta3
1School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017 Jaipur, Rajasthan, India.
Abstract:
Lung cancer (LC) continues to pose a significant global medical burden, necessitating a comprehensive understanding of its molecular foundations to establish effective treatment strategies. The mitogen-activated protein kinase (MAPK) signaling system has been scientifically associated with LC growth; however, the intricate regulatory mechanisms governing this system remain unknown. Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of diverse cellular activities, including cancer growth. LncRNAs have been implicated in LC, which can function as oncogenes or tumor suppressors, and their dysregulation has been linked to cancer cell death, metastasis, spread, and proliferation. Due to their involvement in critical pathophysiological processes, lncRNAs are gaining attention as potential candidates for anti-cancer treatments. This article aims to elucidate the regulatory role of lncRNAs in MAPK signaling in LC. We provide a comprehensive review of the key components of the MAPK pathway and their relevance in LC, focusing on aberrant signaling processes associated with disease progression. By examining recent research and experimental findings, this article examines the molecular mechanisms through which lncRNAs influence MAPK signaling in lung cancer, ultimately contributing to tumor development.
Insights
Long non-coding RNAs (lncRNAs) regulate the MAPK pathway in lung cancer (LC). Understanding lncRNA-MAPK interactions is key for developing novel LC treatments and targeting tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer (LC) remains a major global health challenge.
- The mitogen-activated protein kinase (MAPK) signaling pathway is implicated in LC progression.
- The precise regulatory roles of long non-coding RNAs (lncRNAs) in MAPK signaling within LC are not fully understood.
Purpose of the Study:
- To review the role of lncRNAs in regulating MAPK signaling in lung cancer.
- To explore the molecular mechanisms by which lncRNAs influence MAPK pathway activity in LC.
- To highlight the potential of lncRNAs as therapeutic targets for lung cancer.
Main Methods:
- Literature review of recent research on lncRNAs and MAPK signaling in lung cancer.
- Analysis of experimental findings on lncRNA function in LC.
- Examination of the molecular mechanisms connecting lncRNAs to MAPK pathway dysregulation.
Main Results:
- lncRNAs are critical regulators of cellular processes, including cancer growth.
- Dysregulated lncRNAs are associated with LC cell death, metastasis, and proliferation.
- lncRNAs can act as oncogenes or tumor suppressors in lung cancer.
Conclusions:
- lncRNAs play a significant role in modulating MAPK signaling in lung cancer.
- Targeting lncRNA-MAPK interactions presents a promising avenue for novel lung cancer therapies.
- Further research into lncRNA functions can advance understanding and treatment of lung cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Abnormal Proliferation

